Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_15974
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 15974
Character Range: 965816–967393

15974                                                 Intermediate level dosimetry calculated on a volumetric dataset for intracavitary or intraluminal or endocavity applicators, for brachytherapy plans that have three‑dimensional image datasets acquired as part of simulation, if:                                                                                                      927.75
                                                      (a) the planning process is required to deliver the prescribed dose to a three‑dimensional volume, and relative to multiple line for channel delivery applicators (excluding interstitial catheters and needles and multi‑catheter devices); and
                                                      (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of dose between target, organs at risk and normal tissue dose using avoidance strategies (which include placement of sources and/or dwell‑times or tissue packing); and
                                                      (c) delineation of structures is required as part of the planning process to produce a dose‑volume histogram integral to the avoidance strategies; and
                                                      (d) dose calculations are performed on a personalised basis, which must include three‑dimensional dose calculation to target and organ‑at‑risk volumes; and
                                                      (e) dose calculations and the dose‑volume histogram are approved and recorded with the plan